ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
12 announcements with these filters
MBAPL completed a preferential allotment of 20.72 lakh equity shares at ₹145 to 14 investors. The issuance raises ₹30.05 Crore, expanding paid-up capital to ₹91.77 Crore.
Madhya Bharat Agro Products allotted 2.07 crore shares at ₹145 in a preferential issue, raising ₹300.48 Crore. Post-allotment paid-up capital stands at 4.59 crore equity shares.
Madhya Bharat Agro Products Limited conducted an EGM on August 28, 2026. Shareholders approved a preferential equity issue to non-promoters and an amendment to the Company's Memorandum of Association.
Madhya Bharat Agro issued a corrigendum to its August 28, 2026 EGM notice, modifying the list of allottees for its proposed Rs 317.48 Crore preferential issue.
Madhya Bharat Agro Products Limited issued an EGM notice for August 28, 2026, seeking approval for a preferential issue aggregating ₹317.48 Crore.
Madhya Bharat Agro Products Limited has scheduled an Extra Ordinary General Meeting for August 28, 2026. Shareholders will participate via video conferencing.
Madhya Bharat Agro Products Limited approved a preferential issue of 2,18,95,000 equity shares at Rs. 145 per share, raising up to Rs. 317.48 Crore.
Madhya Bharat Agro Products Limited will hold a board meeting on 29-Jul-2026 to consider a proposed fundraise via preferential issue.
MBAPL reported Q1 FY27 revenue of ₹416.3 Cr (+1.6% YoY) and PAT of ₹33.0 Cr (+17.0% YoY). Strategy focuses on backward integration and massive capacity expansion at Dhule.
Madhya Bharat Agro Products Ltd reported revenue from operations of ₹416.3 Cr (+1.6% YoY) and net profit of ₹33 Cr (+17.0% YoY) for Q1 FY27.
CRISIL assigned CRISIL A+/Watch Developing and CRISIL A1/Watch Developing ratings to MBAPL's Rs. 2006.6 Crore bank facilities. The rating watch reflects developing implications.
Madhya Bharat Agro Products will hold a board meeting on July 14, 2026. The agenda includes reviewing quarterly standalone financial results.